Compare Charles River Laboratories Intl. Inc (CRL) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Wix.Com Ltd — how do they compare? Charles River Laboratories Intl. Inc trades at $301.79 (market cap $14.23B), while Wix.Com Ltd trades at $76.56 (market cap $3.11B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 4.6× Wix.Com Ltd's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Wix.Com Ltd for 62 Days on average.
| CRL | WIX | |
|---|---|---|
Market Cap | $14.23B | $3.11B |
Volume | 1,176,885 | 809,286 |
Sector | Health | Technology |
52-Week High | $310.77 | $145.54 |
52-Week Low | $149.93 | $40.43 |
Typical Hold Time | 33 Days | 62 Days |
Enterprise Value | $17.06B | $4.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $298.00, down 0.77% on the day, with a bullish technical signal supported by moving averages. The company has beaten earnings estimates for three consecutive quarters, though it reported a net loss of -$144.34M for 2025. Analyst consensus is strongly positive with a $305.50 price target, and recent news highlights a strategic growth plan targeting 5%-7% revenue growth by 2030.
The stock's outlook is supported by strong analyst buy ratings and a clear growth strategy, but faces risks from negative profitability metrics and high valuation multiples. Investment opportunity hinges on successful execution of margin expansion and cost savings initiatives, while key risks include persistent net losses and competitive pressures in the healthcare services sector.
Wix.com (WIX) trades at $74.13, up 1.59% with mixed technical signals showing neutral overall but bullish moving averages. The company reported Q2 2026 EPS of $1.39, beating expectations, but faces negative net income margin of -8.19% despite strong revenue growth to $1.99 billion in 2025. Multiple class action lawsuits filed in September 2026 create near-term legal overhang.
Analyst consensus remains positive with 26 buy ratings and $77 price target, but investors face risks from negative cash flow trends, legal challenges, and inconsistent profitability. The stock offers growth potential if Wix can maintain revenue momentum while improving cost controls, but legal proceedings could pressure shares near-term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
